| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
David L Herzog is Director at DXC, with reported holdings spanning 4 companies. David L Herzog's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.2M at current prices.
David L Herzog's largest disclosed position is in MET as Director, worth about $2.6M.
David L Herzog has 80 Form 4 filings on record from March 2016 to September 2026, across 4 companies: Director at Aegon Funding Company LLC 5.10% (AEFC), 2026; Director at DXC Technology (DXC), 2017–2026; Director at Metlife (MET), 2020–2025, and 1 more.
The 81 reported transactions were 63 stock awards, 16 option or other derivative awards, 1 option exercise and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $203K and no sales.
The only open-market purchase was 12,820 shares of OSG at an average $15.84 on March 31, 2016, about $203K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2016 | OSG Octave Specialty Group Inc | Director | Buy | 12,820 | $15.84 | $203,068.80 | New |